Abstract
Cenegermin (Oxervate (TM)), an ophthalmic solution containing 20 mu g/mL of recombinant human nerve growth factor (rhNGF), is the first drug to be app......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
